FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.

FOXP3 is a forkhead transcription factor family member, implicated in T-cell regulation, activation and differentiation. FOXP3 has been shown to be a master control gene for the development and function of CD4+/CD25+ regulatory T-cells (T(reg)). In this study, FOXP3 protein expression has been analy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Roncador, G, Garcia, J, Maestre, L, Lucas, E, Menarguez, J, Ohshima, K, Nakamura, S, Banham, A, Piris, M
Format:	Journal article
Sprache:	English
Veröffentlicht:	2005

Ähnliche Einträge

FOXP3 expression in B and T cell lymphomas.
von: Roncador, G, et al.
Veröffentlicht: (2005)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
von: Barrans, S, et al.
Veröffentlicht: (2004)

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
von: Haralambieva, E, et al.
Veröffentlicht: (2006)

The significance of FOXP1 in diffuse large B-cell lymphoma
von: Gascoyne, D, et al.
Veröffentlicht: (2016)

Is FOXP3 expressed in cutaneous T-cell lymphomas?
von: Banham, A, et al.
Veröffentlicht: (2008)

The FOXP3 transcription factor as a regulatory T-cell marker
von: Banham, A
Veröffentlicht: (2008)

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
von: Carreras, J, et al.
Veröffentlicht: (2006)

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
von: Alvaro, T, et al.
Veröffentlicht: (2005)

Expression of FOXP2 is up-regulated in lymphoid malignancies
von: Campbell, A, et al.
Veröffentlicht: (2009)

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas.
von: Klemke, C, et al.
Veröffentlicht: (2006)

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
von: Wong, K, et al.
Veröffentlicht: (2016)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
von: Brown, P, et al.
Veröffentlicht: (2005)

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.
von: Roncador, G, et al.
Veröffentlicht: (2005)

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
von: Santiago Montes-Moreno, et al.
Veröffentlicht: (2010-08-01)

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.
von: Esperanza Martín-Sánchez, et al.
Veröffentlicht: (2014-01-01)

The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
von: Farinha, P, et al.
Veröffentlicht: (2006)

The architectural pattern of FOXP3*T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
von: Farinha, P, et al.
Veröffentlicht: (2006)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
von: Camilleri, E, et al.
Veröffentlicht: (2012)

FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
von: Goatly, A, et al.
Veröffentlicht: (2008)

FOXP1 abnormalities in lymphoma: Translocation breakpoint mapping reveals insights into deregulated transcriptional control
von: Goatly, A, et al.
Veröffentlicht: (2008)

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
von: Giovanna Roncador, et al.
Veröffentlicht: (2007-08-01)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells.
von: Campbell, A, et al.
Veröffentlicht: (2010)

Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.
von: Banham, A, et al.
Veröffentlicht: (2009)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells: Research paper
von: Campbell, A, et al.
Veröffentlicht: (2010)

MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
von: Borovecki, A, et al.
Veröffentlicht: (2007)

Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
von: Boultwood, J
Veröffentlicht: (2001)

Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
von: Barrans, S, et al.
Veröffentlicht: (2007)

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
von: Banham, A, et al.
Veröffentlicht: (2005)

Adult T-cell leukaemia/lymphoma in an adolescent patient: Expect the unexpected
von: Ibtisam Abdullah, et al.
Veröffentlicht: (2020-05-01)

FOXP3+ regulatory T cells as biomarkers in human malignancies.
von: Bignone, P, et al.
Veröffentlicht: (2008)

FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
von: Raghavan, S, et al.
Veröffentlicht: (2009)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
von: Guinn, B, et al.
Veröffentlicht: (2005)

Strong expression of FOXP1 predicts for poor prognosis within the non-germinal centre subgroup of diffuse large B cell lymphoma
von: Barrans, S, et al.
Veröffentlicht: (2005)

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
von: Fenton, J, et al.
Veröffentlicht: (2006)

Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species.
von: Banham, A, et al.
Veröffentlicht: (2009)

The epidemiology of leukaemias and lymphomas: a review.
von: Kinlen, L
Veröffentlicht: (1977)

Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
von: Mojgan Djavaheri-Mergny, et al.
Veröffentlicht: (2019-01-01)

CRISPR/Cas9-mediated Foxp1 silencing restores immune surveillance in an immunocompetent A20 lymphoma model
von: Felce, SL, et al.
Veröffentlicht: (2020)

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.
von: Banham, A
Veröffentlicht: (2006)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
von: Nyman, H, et al.
Veröffentlicht: (2009)